tradingkey.logo

Bubs Australia Says FDA Continues Review Of Bubs' Infant Formula Submissions

ReutersDec 29, 2025 1:09 AM

- Bubs Australia Ltd BUB.AX:

  • FDA CONTINUES REVIEW OF BUBS' INFANT FORMULA SUBMISSIONS

  • CONFIRMS THAT IT IS ON TRACK TO RECEIVE FDA APPROVAL

  • FDA CONFIRMED IT WILL CONTINUE TO FACILITATE IMPORTATION, OTHERS OF BUBS' INFANT FORMULA PRODUCTS IN US AFTER 31 DEC 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI